Nano-crystalline semiconductors have emerged as a cutting-edge technology with promising applications in the pharmaceutical field. These materials, characterized by their reduced size and unique electronic properties, offer a range of advantages for drug delivery and diagnostic applications. The nanoscale dimensions of these semiconductors facilitate precise control over their optical and electronic properties, enabling targeted drug delivery systems and sensitive diagnostic tools. In drug delivery, nano-crystalline semiconductors can enhance therapeutic efficacy by improving drug solubility, stability, and bioavailability.
Moreover, their tunable optical properties make them ideal candidates for imaging and diagnostic purposes, allowing for real-time monitoring of drug distribution and therapeutic effects. The integration of nano-crystalline semiconductors in pharmaceutical formulations opens up new possibilities for personalized medicine and improved patient outcomes. As research in this field progresses, the potential for innovative and tailored solutions in drug development and delivery within the pharmaceutical industry continues to expand.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil